Boehringer Ingelheim Initiates First Phase III Clinical Trial In Ovarian Cancer

Posted by Jeff Daas on Dec 20th, 2009 | no comments

Boehringer Ingelheim announced today the initiation of a new phase III clinical trial to evaluate one of its two late-stage oncology pipeline compounds for the treatment of patients with advanced ovarian cancer…
Read Full Article